Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis

Abstract

The present invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Leber congenital amaurosis.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jan 1, 2019
  • Application: Apr 26, 2018
    US US 201815963229 A
  • Priority: Apr 26, 2018
    US US 201815963229 A
  • Priority: Jul 21, 2017
    US US 201715656635 A
  • Priority: Jun 16, 2014
    US US 201414342776 A
  • Priority: Apr 25, 2012
    NL NL 2012050275 W
  • Priority: Sep 6, 2011
    US US 201161531137 P
  • Priority: Sep 5, 2011
    NL NL 2007351 A

Download Citation


Sign in to the Lens

Feedback